UPDATE: Walgreen, Caterpillar In Prescription-Drug Pact
August 26 2009 - 11:49AM
Dow Jones News
Walgreen Co. (WAG) will offer prescription drugs directly to
Caterpillar Inc. (CAT) for its workers and retirees, launching a
program that will parallel the one Wal-Stores Inc. (WMY) already
has with the heavy equipment manufacturer.
The Walgreen program announced Wednesday takes effect Jan. 1,
when Wal-Mart's pilot with Caterpillar is scheduled to end.
Caterpillar "has determined our pilot with Wal-Mart was a success"
and has now signed a two-year contract with the retailer that also
starts Jan. 1, said Caterpillar pharmacy benefits manager Todd
Bisping. "We will have a direct agreement with both Walgreen and
Wal-Mart," he said.
Caterpillar went with Walgreen because it wants to expand its
health benefits programs to other pharmacies, said Bisping, who
added that other pharmacy chains could be added.
The program will cover around 70,000 Caterpillar employees,
retirees, and dependants.
A Wal-Mart spokesperson could not immediately be reached for
comment. Wal-Mart started the prescription program with Caterpillar
last September as a way of trying to define itself as a
prescription supplier to corporations. Wal-Mart has said it want to
expand the program, but has so far not announced any other
companies have joined.
As part of its arrangement with Caterpillar, Walgreen will offer
Caterpillar employees discounts on non-pharmacy goods. Walgreen and
Caterpillar are also talking about expanding the program to have
retail clinics onsite at certain Caterpillar offices or near them,
Bisping said.
It's not believed Wal-Mart has either arrangement with
Caterpillar currently. But services, as well as prescription
prices, could change once the formal contract with Wal-Mart is
announced. Right now, Caterpillar is picking up the copay for
employees on generics from Wal-Mart. Employees pay full price,
under their health plans, on brand drugs.
Walgreen operates about 7,000 pharmacies across the U.S., while
Wal-Mart has much less.
-By Karen Talley, Dow Jones Newswires; 212-416-2196;
karen.talley@wsj.com